Impact of Diabetes in Patients Diagnosed With COVID-19

Impact of Diabetes in Patients Diagnosed With COVID-19

COVID-19 is a disease caused by the coronavirus SARS-CoV-2 (Severe Acute Respiratory Syndrome Coronavirus-2), known as a highly contagious disease, currently affecting more than 200 countries worldwide. The main feature of SARS-CoV-2 that distinguishes it from other viruses is the speed of transmiss...

Full description

Bibliographic Details
Main Authors:	Mohamed Abu-Farha, Fahd Al-Mulla, Thangavel Alphonse Thanaraj, Sina Kavalakatt, Hamad Ali, Mohammed Abdul Ghani, Jehad Abubaker
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2020-12-01
Series:	Frontiers in Immunology
Subjects:	coronavirus disease (COVID-19) type 2 diabetes angiotensin converting enzyme2 (ACE2) Furin transmembrane protease serine 2 (TMPRSS2)
Online Access:	https://www.frontiersin.org/articles/10.3389/fimmu.2020.576818/full

Similar Items

Variations in levels of ACE2 and TMPRSS2 receptors among COVID-19
by: Dalia Zanaty, et al.
Published: (2024-02-01)

Eye Washing Downregulated Angiotensin-Converting Enzyme 2 in Conjunctival Tissue Samples from Smokers
by: Hiroshi Fujishima, et al.
Published: (2023-12-01)

Significance of Furin Expression in Thyroid Neoplastic Transformation
by: Maria Teresa Azevedo, et al.
Published: (2023-08-01)

Detection of SARS-CoV-2 infection in thyroid follicular cells from a COVID-19 autopsy series
by: Sofia Macedo, et al.
Published: (2023-01-01)

Pathophysiological conditions induced by SARS-CoV-2 infection reduce ACE2 expression in the lung
by: Yoko Miura, et al.
Published: (2022-11-01)

Host Serine Proteases: A Potential Targeted Therapy for COVID-19 and Influenza
by: Yalda Rahbar Saadat, et al.
Published: (2021-08-01)

Angiotensin-Converting Enzyme 2 (ACE2), Transmembrane Peptidase Serine 2 (TMPRSS2), and Furin Expression Increases in the Lungs of Patients with Idiopathic Pulmonary Fibrosis (IPF) and Lymphangioleiomyomatosis (LAM): Implications for SARS-CoV-2 (COVID-19) Infections
by: Wenying Lu, et al.
Published: (2022-01-01)

Smoke and Spike: Benzo[a]pyrene Enhances SARS‐CoV‐2 Infection by Boosting NR4A2‐Induced ACE2 and TMPRSS2 Expression
by: Wenbin Liu, et al.
Published: (2023-09-01)

The Two Faces of ACE2: The Role of ACE2 Receptor and Its Polymorphisms in Hypertension and COVID-19
by: Mira Bosso, et al.
Published: (2020-09-01)

A Testimony of the Surgent SARS-CoV-2 in the Immunological Panorama of the Human Host
by: Rinki Minakshi, et al.
Published: (2020-10-01)

Unraveling the Link between Periodontitis and Coronavirus Disease 2019: Exploring Pathogenic Pathways and Clinical Implications
by: En-Chin Lin, et al.
Published: (2023-10-01)

Restriction of Viral Glycoprotein Maturation by Cellular Protease Inhibitors
by: Rishikesh Lotke, et al.
Published: (2024-02-01)

Generation of SARS-CoV-2 Spike Pseudotyped Virus for Viral Entry and Neutralization Assays: A 1-Week Protocol
by: Jose Manuel Condor Capcha, et al.
Published: (2021-01-01)

New hope for treatment of respiratory involvement following COVID-19 by bromhexine
by: Abdolrazagh Barzegar, et al.
Published: (2021-05-01)

Nasopharyngeal Expression of Angiotensin-Converting Enzyme 2 and Transmembrane Serine Protease 2 in Children within SARS-CoV-2-Infected Family Clusters
by: Mohammad Rubayet Hasan, et al.
Published: (2021-12-01)

Bioinformatics Analysis of Allele Frequencies and Expression Patterns of ACE2, TMPRSS2 and FURIN in Different Populations and Susceptibility to SARS-CoV-2
by: Mohammad Tarek, et al.
Published: (2021-07-01)

SARS-CoV-2 Entry Genes Expression in Relation with Interferon Response in Cystic Fibrosis Patients
by: Camilla Bitossi, et al.
Published: (2021-01-01)

Expression of SARS-CoV-2 entry receptors in the respiratory tract of healthy individuals, smokers and asthmatics
by: Magdalena Matusiak, et al.
Published: (2020-09-01)

Association of Cigarette Smoking, COPD, and Lung Cancer With Expression of SARS-CoV-2 Entry Genes in Human Airway Epithelial Cells
by: Junping Yin, et al.
Published: (2020-12-01)

A New Butyrate Releaser Exerts a Protective Action against SARS-CoV-2 Infection in Human Intestine
by: Lorella Paparo, et al.
Published: (2022-01-01)

Corrigendum: Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
by: Roberto Berni Canani, et al.
Published: (2021-11-01)

Age-Related Differences in the Expression of Most Relevant Mediators of SARS-CoV-2 Infection in Human Respiratory and Gastrointestinal Tract
by: Roberto Berni Canani, et al.
Published: (2021-07-01)

Lipid Raft Integrity and Cellular Cholesterol Homeostasis Are Critical for SARS-CoV-2 Entry into Cells
by: Ahmed Bakillah, et al.
Published: (2022-08-01)

RAndomized Clinical Trial Of NAfamostat Mesylate, A Potent Transmembrane Protease Serine 2 (TMPRSS2) Inhibitor, in Patients with COVID-19 Pneumonia
by: Teresa Maria Seccia, et al.
Published: (2023-10-01)

RECURRENT OF TMPRSS2 GENETIC POLYMORPHISM AND ITS ROLE IN IRAQI PATIENTS WITH PROSTATE CANCER
by: Ammar K. A., et al.
Published: (2022-04-01)

Exploring the potential mechanisms of impairment on genitourinary system associated with coronavirus disease 2019 infection: Bioinformatics and molecular simulation analyses
by: Kai Zhao, et al.
Published: (2023-07-01)

Presence of SARS-CoV-2 and Its Entry Factors in Oral Tissues and Cells: A Systematic Review
by: Marco Felipe Salas Orozco, et al.
Published: (2021-05-01)

The Potential Role of Osteopontin and Furin in Worsening Disease Outcomes in COVID-19 Patients with Pre-Existing Diabetes
by: Yvonne Adu-Agyeiwaah, et al.
Published: (2020-11-01)

New insights into genetic susceptibility of COVID-19: an ACE2 and TMPRSS2 polymorphism analysis
by: Yuan Hou, et al.
Published: (2020-07-01)

Association of the Transmembrane Serine Protease-2 (TMPRSS2) Polymorphisms with COVID-19
by: Rosalinda Posadas-Sánchez, et al.
Published: (2022-09-01)

SARS-CoV-2 effects in the genitourinary system and prospects of sex hormone therapy
by: Kuangzheng Liu, et al.
Published: (2021-07-01)

Gastrointestinal cancers, ACE-2/TMPRSS2 expression and susceptibility to COVID-19
by: Sepehr Shafiee, et al.
Published: (2021-08-01)

In Silico Screening of Novel TMPRSS2 Inhibitors for Treatment of COVID-19
by: Shuo Wang, et al.
Published: (2022-06-01)

Blockade of TMPRSS2-mediated priming of SARS-CoV-2 by lactoferricin
by: Anna Ohradanova-Repic, et al.
Published: (2022-08-01)

Tamarind (Tamarindus indica L.) Seed a Candidate Protein Source with Potential for Combating SARS-CoV-2 Infection in Obesity
by: Ana H. de A. Morais, et al.
Published: (2021-04-01)

TMPRSS2 and MSPL Facilitate Trypsin-Independent Porcine Epidemic Diarrhea Virus Replication in Vero Cells
by: Wen Shi, et al.
Published: (2017-05-01)

Renal Carcinoma Is Associated With Increased Risk of Coronavirus Infections
by: Satyendra C. Tripathi, et al.
Published: (2020-11-01)

Curcumin as a potential multiple-target inhibitor against SARS-CoV-2 infection: A detailed interaction study using quantum chemical calculations
by: Kumar Sumit
Published: (2023-01-01)

ACE-2, TMPRSS2 and Beyond; Promising Targets and Tools for COVID-19 Prophylaxis and Treatment
by: Akçahan GEPDİREMEN, et al.
Published: (2020-12-01)

Manifestations of coronavirus infection disease-19 in anterior eye segment: An up-to-date review
by: Basheer Abdullah Marzoog
Published: (2024-01-01)